pharmaphorum
DECEMBER 30, 2022
The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new survey of 200 GPs in the UK. Just 4% of would choose the hospital as the preferred location of testing, compared to 46% for the GP surgery, 18% for a community hub, 15% for a patient’s home and 12% for the pharmacy.
Pharma Pathway
DECEMBER 30, 2022
Zenfold Sustainable Technology (ZST)- Openings for Production / Stores Dept. -Apply Now. Job Description. Openings with Zenfold Sustainable Technology (Specialty Chemicals, API) for Production / Stores Departments. Department: Production / Stores. Position: Chemist/ Officer/ Executive. Qualification: B.Sc/ M.Sc/ B.Tech. Experience: 02 to 05 years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 30, 2022
Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and what specifically had attracted Verheul to attend. Chatting about Graphite Digital’s role as a design specialist for HCPs, patient groups, and ‘everything in between’ – the vision and purpose that encircles that – Verheul and I look at the conversations being sparked at the event, the challenges that are clear across industries
Pharma Pathway
DECEMBER 30, 2022
Alembic Pharmaceuticals Ltd- Openings for Trainee- IT Helpdesk – Apply Now. Job Description. Alembic Pharmaceuticals Ltd. is an Indian multinational Pharmaceutical company headquartered in Vadodara city of Gujarat-India. Alembic pharmaceuticals Ltd. is involved in manufacture of pharmaceutical products, pharmaceutical substances and Intermediates.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
DECEMBER 30, 2022
The FDA’s interactions with Biogen in the build-up to last year’s controversial approval of Alzheimer’s disease therapy Aduhelm have been described as “inappropriate” and “atypical” in a congressional report on the review. The document produced by Oversight and Reform Committee chair Carolyn Maloney (D-NY) and Energy and Commerce Committee chair Frank Pallone Jr (D-NJ) also points to “collaboration” between Biogen and the FDA ahead of an advi
PharmExec
DECEMBER 30, 2022
AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Commerce
DECEMBER 30, 2022
The latest people news happenings over the past month.
Pharmacy Times
DECEMBER 30, 2022
This month's clinical pharmacology update looks at a medication to manage Helicobacter pylori infection in adults.
Celeritas
DECEMBER 30, 2022
Last year, the universe of renewables was shaken by the exposure and downfall of a billion-dollar EV company, Nikola. The debacle shocked Wallstreet and raised many questions about the feasibility of Hydrogen as a potential path to a carbon-zero future. We can say without much meandering that there is no clear answer to those questions, even a year later as the trial has just played out.
Pharmacy Times
DECEMBER 30, 2022
New drug approvals, toxicity management, and pharmacists’ roles in cancer care all dominated the top oncology articles of 2022.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmacy Times
DECEMBER 30, 2022
Products include the generic alternatives to Esbriet and Oracea.
Expert insights. Personalized for you.
92 
Let's personalize your content